| [1] |
Mrowietz U, Lauffer F, Sondermann W, et al. Psoriasis as a sys-temic disease[J]. Dtsch Arztebl Int, 2024, 121(14):467-472.
|
| [2] |
中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会, 等. 中国银屑病生物制剂及小分子药物治疗指南(2024版)[J]. 中华皮肤科杂志, 2024, 57(11):976-997.
|
|
Chinese Society of Dermatology, China Dermatologist Associa-tion, Dermatology & Venereology Specialized Committee of Chinese Association of Integrative Medicine, et al. Guidelines for the treatment of psoriasis with biologics and small-molecule drugs in China(2024 edition)[J]. Chin J Dermatol, 2024, 57(11):976-997.
|
| [3] |
Malagoli P, Dapavo P, Amerio P, et al. Secukinumab in the treat-ment of psoriasis:a narrative review on early treatment and real-world evidence[J]. Dermatol Ther, 2024, 14(10):2739-2757.
DOI
|
| [4] |
Lebwohl MG, Kavanaugh A, Armstrong AW, et al. US perspec-tives in the management of psoriasis and psoriatic arthritis:patient and physician results from the population-based multi-national assessment of psoriasis and psoriatic arthritis(MAPP)survey[J]. Am J Clin Dermatol, 2016, 17(1):87-97.
DOI
PMID
|
| [5] |
孟祥敏, 王倩, 闫荣, 等. 结直肠癌患者报告结局评估工具及临床应用的研究进展[J]. 中华护理杂志, 2022, 57(9):1094-1099.
DOI
URL
|
|
Meng XM, Wang Q, Yan R, et al. Research progress on asses-sment tools of patient-reported outcomes for colorectal cancer patients and the clinical application[J]. Chin J Nurs, 2022, 57(9):1094-1099.
|
| [6] |
Prinsen CAC, Mokkink LB, Bouter LM, et al. COSMIN guideline for systematic reviews of patient-reported outcome measures[J]. Qual Life Res, 2018, 27(5):1147-1157.
DOI
PMID
|
| [7] |
Elsman EBM, Mokkink LB, Terwee CB, et al. Guideline for re-porting systematic reviews of outcome measurement instruments (OMIs):PRISMA-COSMIN for OMIs 2024[J]. J Clin Epidemiol, 2024, 173:111422.
DOI
URL
|
| [8] |
Mokkink LB, Prinsen CA, Bouter LM, et al. The COnsensus-based Standards for the selection of health Measurement INstruments(COSMIN) and how to select an outcome measurement instrument[J]. Braz J Phys Ther, 2016, 20(2):105-113.
DOI
URL
|
| [9] |
Mokkink LB, de Vet HCW, Prinsen CAC, et al. COSMIN risk of bias checklist for systematic reviews of patient-reported outcome measures[J]. Qual Life Res, 2018, 27(5):1171-1179.
DOI
PMID
|
| [10] |
Gagnier JJ, Lai JY, Mokkink LB, et al. COSMIN reporting gui-deline for studies on measurement properties of patient-repor-ted outcome measures[J]. Qual Life Res, 2021, 30(8):2197-2218.
DOI
PMID
|
| [11] |
Alhazzani W, Guyatt G. An overview of the GRADE approach and a peek at the future[J]. Med J Aust, 2018, 209(7):291-292.
PMID
|
| [12] |
He ZH, Lu CJ, Ou AH, et al. Reliability and validity of the Chinese version of the Psoriasis Disability Index(PDI) in Chinese patients with psoriasis[J]. Health Qual Life Outcomes, 2012, 10:37.
DOI
|
| [13] |
Nijsten T, Unaeze J, Stern RS. Refinement and reduction of the Impact of Psoriasis Questionnaire:classical test theory vs. Rasch analysis[J]. Br J Dermatol, 2006, 154(4):692-700.
DOI
URL
|
| [14] |
McKenna SP, Cook SA, Whalley D, et al. Development of the PSORIQoL,a psoriasis-specific measure of quality of life de-signed for use in clinical practice and trials[J]. Br J Derma-tol, 2003, 149(2):323-331.
|
| [15] |
Revicki DA, Jin Y, Wilson HD, et al. Reliability and validity of the Psoriasis Symptom Inventory in patients with moderate-to-severe psoriasis[J]. J Dermatolog Treat, 2014, 25(1):8-14.
DOI
PMID
|
| [16] |
Chularojanamontri L, Griffiths CE, Chalmers RJ. The Simplified Psoriasis Index(SPI):a practical tool for assessing psoriasis[J]. J Invest Dermatol, 2013, 133(8):1956-1962.
DOI
PMID
|
| [17] |
Mathias SD, Feldman SR, Crosby RD, et al. Measurement pro-perties of a patient-reported outcome measure assessing pso-riasis severity:the psoriasis symptoms and signs diary[J]. J Der-matolog Treat, 2016, 27(4):322-327.
|
| [18] |
McKenna SP, Doward LC, Whalley D, et al. Development of the PsAQoL:a quality of life instrument specific to psoriatic ar-thritis[J]. Ann Rheum Dis, 2004, 63(2):162-169.
DOI
PMID
|
| [19] |
Duruöz MT, Nas K, Acer Kasman S, et al. Validity and psy-chometric characteristics of the Psoriatic Arthritis Quality of Life(PSAQoL) Questionnaire in the Turkish population[J]. Rheu-matol Int, 2025, 45(7):155.
|
| [20] |
Gossec L, de Wit M, Kiltz U, et al. A patient-derived and pa-tient-reported outcome measure for assessing psoriatic arthritis:elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease(PsAID) Questionnaire,a 13-coun-try EULAR initiative[J]. Ann Rheum Dis, 2014, 73(6):1012-1019.
DOI
PMID
|
| [21] |
Ortonne JP, Baran R, Corvest M, et al. Development and vali-dation of Nail Psoriasis Quality of Life Scale(NPQ10)[J]. Acad Dermatol Venereol, 2010, 24(1):22-27.
DOI
URL
|
| [22] |
Augustin M, Blome C, Costanzo A, et al. Nail Assessment in Psoriasis and Psoriatic Arthritis(NAPPA):development and validation of a tool for assessment of nail psoriasis outcomes[J]. Br J Dermatol, 2014, 170(3):591-598.
DOI
PMID
|
| [23] |
夏萍, 卢传坚, 闫玉红. NAPPA-QOL中文版在甲银屑病患者应用中的信度和效度评价[J]. 中国皮肤性病学杂志, 2021, 35(3):317-324.
|
|
Xia P, Lu CJ, Yan YH. Reliability and validity of the Chinese version of NAPPA-QOL for nail psoriasis patients[J]. Chin J Dermatovenereology, 2021, 35(3):317-324.
|
| [24] |
彭颖洁, 刘艾红, 朱文莉, 等. 老年人预立医疗照护计划准备度评估工具的系统评价[J]. 中华护理杂志, 2025, 60(9):1146-1152,封3.
DOI
URL
|
|
Peng YJ, Liu AH, Zhu WL, et al. Systematic review of readi-ness assessment tools for advance care planning in older adults[J]. Chin J Nurs, 2025, 60(9):1146-1152,3rd cover.
|
| [25] |
Gallo L, Rae C, Kim PJ, et al. Establishing test-retest reliabi-lity and the smallest detectable change of FACE-Q aesthetic module scales[J]. J Plast Reconstr Aesthet Surg, 2024, 95:231-238.
DOI
URL
|
| [26] |
Mokkink LB, Elsman EBM, Terwee CB. COSMIN guideline for systematic reviews of patient-reported outcome measures version 2.0[J]. Qual Life Res, 2024, 33(11):2929-2939.
DOI
|
| [27] |
朱璐, 何竹, 赵息, 等. 中文版血液透析患者饮食与营养认知行为评估工具的系统评价[J]. 中华护理教育, 2024, 21(11):1371-1377.
|
|
Zhu L, He Z, Zhao X, et al. Systematic review of the Chinese version of the assessment tool for cognitive behavior of diet and nutrition among hemodialysis patients[J]. Chin J Nurs Educ, 2024, 21(11):1371-1377.
|
| [28] |
陆诗燕, 刘羡, 江笑笑, 等. 肝癌患者特异性自我报告结局评估工具测量学属性的系统评价[J]. 中华护理杂志, 2024, 59(22):2734-2741.
DOI
URL
|
|
Lu SY, Liu X, Jiang XX, et al. Systematic review of measure-ment properties of liver cancer patient specific self-reported outcome assessment tools[J]. Chin J Nurs, 2024, 59(22):2734-2741.
|
| [29] |
王旋, 温贤秀, 苟莉, 等. 心脏康复依从性评估工具测量学属性的系统评价[J]. 中华护理杂志, 2024, 59(6):736-743.
DOI
URL
|
|
Wang X, Wen XX, Gou L, et al. The cardiac rehabilitation adherence assessment tools:a systematic review of psychometric properties[J]. Chin J Nurs, 2024, 59(6):736-743.
|
| [30] |
López-Medina C, Gorlier C, Orbai AM, et al. Variability of Psoriatic Arthritis Impact of Disease Questionnaire(PsAID12) thresholds in psoriatic arthritis:data from the ReFlaP study[J]. Rheumatology(Oxford), 2025, 64(5):3090-3094.
DOI
URL
|
| [31] |
Blome C, Augustin M, Klein TM. Nail Psoriasis and Quality-of-Life Measurement in clinical trials:call for the use of nail-specific instruments[J]. Am J Clin Dermatol, 2021, 22(6):747-755.
DOI
|